Results 11 to 20 of about 190,183 (351)

The preliminary multicenter retrospective study on the efficacy and safety of thermal ablation for follicular thyroid neoplasms ≤ 3 cm. [PDF]

Discov Oncol
Liu YT, Fan BQ, He JF, Zhou Y, Wu SS, Wang SR, Dong G, Guo JQ, Wei Y, Zhao ZL, Wu J, Cao SL, Yu N, Li Y, Peng LL, Yu MA.   +15 more
europepmc   +2 more sources

Thyroid, thyroid neoplasms and metformin

Клиническая и экспериментальная тиреоидология, 2011

doaj   +2 more sources

The Potential Diagnostic Utility of TROP-2 in Thyroid Neoplasms. [PDF]

Appl Immunohistochem Mol Morphol, 2017
Liu H, Shi J, Lin F.
europepmc   +2 more sources

Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach [PDF]

Endocrinology and Metabolism, 2022
The fifth edition of the World Health Organization (WHO) histologic classification of thyroid neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a grading system.
Chan Kwon Jung, Andrey Bychkov, Kennichi Kakudo   +2 more
doaj   +1 more source

Diagnostic Utility of Immunohistochemistry Markers Galectin-3, CK19 and CD56 in Thyroid Neoplasms: A Descriptive Study [PDF]

Journal of Clinical and Diagnostic Research, 2022
Introduction: The spectrum of follicular patterned thyroid lesions vary from benign to malignant, their categorisation based solely on morphology can often be equivocal.
Jayasree Raman, Febby K Philip, UnniKrishnan Govind   +2 more
doaj   +1 more source

HBME-1 expression by thyroid neoplasms in a Nigerian tertiary health Centre

Ibom Medical Journal, 2023
Aim: The aim of this study is to review the histopathological diagnosis of thyroid neoplasms seen in OAUTHC Ile Ife using HBME-1 immunohistochemical marker. Materials and methods: We studied all thyroid neoplasms diagnosed in the Department of Morbid
Soremekun AI, Olaofe OO, Komolafe AO
doaj   +1 more source

Diagnostic Value of CK19, HBME-1 and TROP2 Biomarkers in Identification of Different Types of Thyroid Follicular Neoplasms

Acta Medica Iranica, 2021
Thyroid malignancies are found in 7% to 15% of all thyroid nodules. Immunohistochemical markers, including CK19, HBME-1and TROP2, have shown an effective role in identifying these malignancies.
Masoud Mohebbi, Shohreh Vojuhi, Zohreh Mousavi, Mohammadali Yaghoubi, Reza Ziaolhagh   +4 more
doaj   +1 more source

Concomitant bilateral papillary thyroid carcinoma and parathyroid adenoma

Case Reports in Clinical Practice, 2022
Thyroid malignant neoplasms are the most prevalent cancer of the endocrine system, and their concurrence with parathyroid neoplasms is extremely rare.
Reza Hajebi, Elham Nazar, Shabnam Mashhadi   +2 more
doaj   +1 more source

Galectin-3 Immunohistochemical Expression in Thyroid Neoplasms [PDF]

Journal of Clinical and Diagnostic Research, 2015
Background: Galectin-3 has been implicated in the regulation of cellular growth, differentiation and malignant transformation in various organs including thyroid gland. It has been extensively studied as an immunohistochemical (IHC) marker in thyroid
B S Sumana, Sampangiram Shashidhar, A S Shivarudrappa   +2 more
doaj   +1 more source

New biomarkers: prospect for diagnosis and monitoring of thyroid disease

Frontiers in Endocrinology, 2023
After the metabolic syndrome and its components, thyroid disorders represent the most common endocrine disorders, with increasing prevalence in the last two decades.
Mirjana T. Macvanin, Zoran M. Gluvic, Bozidarka L. Zaric, Magbubah Essack, Magbubah Essack, Xin Gao, Xin Gao, Esma R. Isenovic   +7 more
doaj   +1 more source